Perfromance Wealth Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Sell |
28,626
-6,370
| -18% | -$556K | 0.08% | 45 |
|
|
2025
Q1 | $2.39M | Hold |
34,996
| – | – | 0.09% | 42 |
|
|
2024
Q4 | $2.72M | Buy |
34,996
+1,420
| +4% | +$110K | 0.09% | 37 |
|
|
2024
Q3 | $2.25M | Sell |
33,576
-570
| -2% | -$38.2K | 0.08% | 42 |
|
|
2024
Q2 | $3.87M | Hold |
34,146
| – | – | 0.14% | 27 |
|
|
2024
Q1 | $4.74M | Sell |
34,146
-2,941
| -8% | -$408K | 0.2% | 34 |
|
|
2023
Q4 | $4.6M | Sell |
37,087
-2,664
| -7% | -$331K | 0.2% | 39 |
|
|
2023
Q3 | $3.71M | Sell |
39,751
-900
| -2% | -$84K | 0.18% | 47 |
|
|
2023
Q2 | $5.21M | Buy |
40,651
+680
| +2% | +$87.1K | 0.24% | 34 |
|
|
2023
Q1 | $4.64M | Buy |
39,971
+14,483
| +57% | +$1.68M | 0.24% | 36 |
|
|
2022
Q4 | $2.89M | Buy |
25,488
+1,500
| +6% | +$170K | 0.17% | 42 |
|
|
2022
Q3 | $1.93M | Sell |
23,988
-880
| -4% | -$70.9K | 0.11% | 47 |
|
|
2022
Q2 | $1.85M | Buy |
24,868
+80
| +0.3% | +$5.96K | 0.1% | 50 |
|
|
2022
Q1 | $3.17M | Hold |
24,788
| – | – | 0.14% | 43 |
|
|
2021
Q4 | $3.33M | Buy |
+24,788
| New | +$3.33M | 0.13% | 48 |
|